Lipitor May Reduce The Risk Of Colorectal Cancer

Here is another reason for your doctor to put you on a Statin, and another reason why Pfizer will be really sorry to lose their patent protection on the best selling Statin drug Lipitor. A researcher at the University of Michigan has found that not only is that class of medications good for helping prevent heart attacks and strokes. It may also reduce the risk of Colon and Rectal cancers by 12% if his reading of the statistics is correct.

Dr. Jewel Samader says the effect works for all of the statin anti-cholesterol drugs. He crunched the data from 22 scientific studies and found a statistical link. He says he has no idea why it works, that would take additional research.

Pfizer loses patent exclusivity on Lipitor in November of next year. Colorectal Cancer is the second leading cause of cancer related deaths each year in the U.S. 150-thousand are diagnosed with the disease each year.

Via : wtvbam